Wednesday, September 20, 2017

Lambert Academic Journals: OmniScriptum, OmniWaste

Lambert Academic Publishers (LAP) is "an imprint of OmniScriptum." It seeks to publish as many of the "invaluable" "5,000,000 theses [that] are written worldwide in the research industry" that it can get its hand on. According to an article in Slate, with the aid of Amazon.com, it also sells collections of Wikipedia articles as its own books. For additional adverse reports, see
⊡ Warning from Bond University Library about "Your Thesis and the Predatory Publisher"
⊡ Blog reporting use of stock photos as pictures of editors
⊡ Same blogger claiming LAP is "a company based in Mauritius and Eastern Europe" rather than Germany, as advertised
Email
From: Dyviah Ramnatsing [d.ramnatsing@lap-publishing.com]
Sent: Thursday, September 14, 2017, 6:09:35 AM EDT
Re: Inquiry regarding Kaye D’s work at the Penn State University
Dear Kaye D,
I wanted to confirm if you received my previous email about the free-of-charge publishing of your work « KINSHIP MATCHING WITH DNA DATABASES (AKA “FAMILIAL SEARCHING”): LEGAL AND ETHICAL ARGUMENTS » [an obscure 2011 talk that never was reduced to writing]. Just in case you need additional information to decide – here is an overview of what we do and who our authors are - http://brochure.omniscriptum.com/info-lap/0537275001445433253. Please give me a short feedback if you are interested in getting your work published. We would surely be sad to see your work's full potential go un-explored, and you would give us a hard time finding something similar in your field of research, so please take a moment to consider before blindly saying no. Thank you in advance!
Sincere regards, Dyviah Ramnatsing, Editor

Saturday, September 2, 2017

Cambridge Scholars Publishing

Cambridge Scholars Publishing's putative link to Cambridge is that it was "Founded by former lecturers and researchers from the University of Cambridge." According to the website's description of the 67 advisory board members (9/2/17), exactly one has a current or former connection to the University of Cambridge. (Terri Apter is a Fellow Emerita of Newman College.) The mailing address is in Newcastle, not Cambridge.

The website states that "We ... do not require any fees be paid to us for publication purposes." Hence, characterizing the business as predatory -- it was on Beall's list of possible predators -- would seems extreme. The quality of the books is debated at Political Science Rumors. A few respondents comment (mostly adversely) on what they have read.

The journals do not look stellar. No editorial boards are listed, although the "editorial advisors" may serve that function. "The International Journal of American Studies is a peer reviewed journal to be launched in spring/summer 2013 ... All manuscripts should be sent electronically to: Irakli Tskhvediani (iraklitskhvediani@yahoo.com; jdpag2012@yahoo.com) by the 30th of April, 2013." The journal is said to be "supported by" the US Embassy in Georgia.This seems to mean that "In 2012 US Department of State and Public Affairs Section of the US Embassy in Tbilisi, Georgia granted him a Federal Assistance Award to set up the publication of a peer-reviewed journal of American Studies." Five years later, the journal is still "awaiting book cover" and has no content.
Email
From: Adam Rummens (adam.rummens@cambridgescholars.com)
Sent: Aug 31 at 9:03 AM
Subject: Decision Science Books
Dear Dr. Kaye,
Firstly, please excuse this unsolicited email. I’m sure that like me you receive too many as it is and so I’ll keep it brief. I was recently appointed as Commissioning Researcher for Cambridge Scholars Publishing (see below) with a brief to expand the subject areas in which we publish books. As such I am in the process of developing collections within the decision sciences. As I believe you already have some experience of academic and scientific writing, I wondered whether you would consider us as your publisher should you decide to put ‘pen to paper’ and write a book at some point in the future?
We are also developing Editorial Advisory Groups to help ensure that we only publish high quality texts. If this is something that you would like to learn more about, please do let me know.
As I promised, I have kept this message short, but would be delighted to talk or correspond more if you feel you would like to explore possibilities.
Kind regards, Adam Rummens, Commissioning Researcher
About Cambridge Scholars Publishing (www.cambridgescholars.com):
Cambridge Scholars Publishing (CSP) is an independent academic publisher, founded in 2001 by former lecturers and researchers from the University of Cambridge who felt existing publishing companies took too long to publish academic books, monographs, conference proceedings and textbooks.
CSP has its own printing facility, now publishes 750+ titles each year in both electronic and print formats and is committed to providing a forward-thinking publishing service that champions original thinking, whilst ensuring we put our authors at the heart of everything we do. Our back list catalogue contains approximately 7,500 titles.
Cambridge Scholars Publishing Ltd is registered in England. Reg. No: 4333775; VAT No: 108280727
Disclaimer: The views and opinions expressed in this message do not necessarily represent those of Cambridge Scholars Publishing Ltd. The contents of this message are intended for the addressee only. They are confidential and may contain private information. Cambridge Scholars Publishing is not responsible for any damages resulting from the unauthorised use, forwarding or disclosure of this message, and will not be held liable for damages or loss caused by any viruses.

Friday, September 1, 2017

Are Drug Companies Supporting Predatory Journals and Conferences?

An article in Bloomberg Businessweek,,August 29, 2017, and reprinted in the September 4, 2017, issue of Bloomberg BNA’s Expert Evidence Report (a resource for lawyers) includes a detailed exposé of the pharmaceutical industry’s participation in flaky medical journals and conferences. It focuses on OMICS International, which threatened a librarian who called it “predatory,” with a billion dollar lawsuit. (An example of the articles OMICS publishes is here.) Excerpts from the BNA report follow, but the article is worth reading in full.
... Omics [claims] 1,000 open-access journal titles that post 50,000 articles annually in fields including medicine, technology, and engineering. It has also built a robust conference division that will hold about 3,000 events worldwide this year. ... Professors and researchers have identified [its CEO and founder, Srinubabu] Gedela as the progenitor of a fraudulent empire that's eroding public trust in scientific inquiry. He denies it all, continuing to extend his global reach from Hyderabad. And he has received help from an unexpected source: the pharmaceutical industry, which regularly publishes in the company's journals and attends its conferences, bringing Omics both credibility and the funds to grow.

... The National Institutes of Health ... banned Omic's journals from indexing in PubMed Central, one of the world's primary databases for medical research, given “serious concerns” about its practices. In 2013, HHS accused Omics of trademark infringement and using the names of employees at the NIH and PubMed Central “in an erroneous and/or misleading manner.” ...
According to financial documents filed with the Indian government, Omics's fiscal 2016 revenue was $11.6 million and profit about $1.2 million. ...

The online journals featured on the Omics home page are rife with grammar glitches and low-resolution headshots. Despite such obvious red flags, Bloomberg Businessweek found that researchers at major pharmaceutical companies, including AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, and Merck, submit to Omics journals and participate in their conferences. Pfizer, the biggest U.S. drugmaker, has published at least 23 articles since 2011, including two since the FTC's lawsuit [accusing OMICS of fraud].

Pfizer wouldn't respond to study-specific questions and declined interview requests. “Our priority is to publish Pfizer-sponsored clinical research in a transparent, accurate, and fair manner,” spokesman Steven Danehy wrote in an email. “We are concerned by the allegations brought forward by the FTC and await the outcome of the investigation.”

AstraZeneca Plc, the second-biggest drugmaker in the U.S., has published at least five articles in Omics journals since 2011 ... When contacted by Bloomberg Businessweek, spokeswoman Abigail Bozarth said AstraZeneca has asked staff to no longer publish in “identified predatory journals,” yet declined to say when that policy change was made. ...

Drugmakers have fueled Omics's rise by also sponsoring and attending conferences, which Gedela says generate 60 percent of Omics's revenue. In a meeting room at the company, photographs taken at conferences, beginning in 2010, show the names of Novartis, Axis Clinicals, and Agilent Technologies as sponsors on screens behind speakers. Drugmaker employees often lead workshops at the events ... Agilent, Axis, and Merck didn't respond to requests for comment. Eli Lilly declined to discuss its involvement with the conferences. Novartis spokesman Eric Althoff declined to comment specifically on Omics, saying his company reviews quality of agenda and “legitimacy of the organization” when conferences seek its sponsorship. GlaxoSmithKline spokeswoman Mary Anne Rhyne says the company allows authors to pick their own journals, though in-house experts suggest reputable publications when asked. Omics conferences “were not on our radar as problematic,” she says, adding: “It's not always easy to spot questionable outlets. Staff training in this area is ongoing.”
Any claim that it is not easy to spot OMICS conferences as “problematic” is preposterous. Five minutes of Googling would do it. Any suggestion that these companies need to await the outcome of an FTC complaint to determine that OMICS (or other publications) are not appropriate venues for publishing their research is silly. The websites of (and the spam from) many of these journals give lip service to peer review and quality editing, but they are filled with obvious warning signs that belie these protestations.


Of course, big pharma is hardly the only source of revenue for OMICS, BIT Group Global, and the flotilla of other flaky publishers and conference organizers. Universities need policies that discourage their faculty from padding CVs with membership on the editorial boards of certain journals; from resorting to publishing in these journals; and from dallying in Dalian.

Wednesday, August 30, 2017

The Pulsus Group Is an OMICS Company

The Pulsus Group of journals were sold to OMICS in 2016. The domain cmesocietyconferences.com, which Pulsus used in the email to me is registered to Srinubabu Gedela, CEO and founder of the OMICS Group. Incredibly, the email denies that it is a promotional message and refers to my "eminence in the field" of osteoporosis.The the email promises to publish all abstracts from a conference on osteoporosis in a journal.on trauma surgery.
Email
From: Osteoporosis Congress 2017 (osteoporosis@cmesocietymeeting.org)
Sent: Tuesday, August 29, 2017 1:49 AM
Re: Gentle Reminder: Abstract submission | Osteoporosis Congress
Dear Colleague, We take the pleasure of inviting you to attend and present at the Eleventh International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders which is slated to hold from December 4-5, 2017 in Madrid, Spain. The purpose of this 2-day conference is to bring together physicians and researchers from around the world who are interested in exploring the link between Osteoporosis, Arthritis and Musculoskeletal Disorders with a broad theme Osteoporosis and Musculoskeletal Disorders as the primary health concern. The conference will focus on topics such as Juvenile Arthritis, Rheumatoid Arthritis, Orthopedic Surgeries, Musculoskeletal Regenerative Medicine, Orthopedic Nursing and many other important topics. The conference is hosted by Pulsus Group which is an ardent supporter of international medical research, and publishes 50+ journals in association with 20+ International medical and scientific societies. All the accepted abstracts will be published in the conference proceedings and in the special edition of JOURNAL OF ORTHOPAEDICS TRAUMA SURGERY AND RELATED RESEARCH with ISSN: 1897-2276 and e-ISSN: 2449-9145. ...
We believe this congress will be a highly rewarding educational and networking experience for all. To know more about the congress and like to submit your abstract or registrations please visit our Osteoporosis Conferences Website ... Thank you for reading, and we very much look forward to hearing from you.
Sincerely Yours,
Dwane Harrison | Program Director, Osteoporosis Congress 2017, PULSUS Medical Meetings, 40 Bloomsbury Way, Lower Ground Floor, London United Kingdom WC1A 2SE Ph.: +44-203-769-1765, Customer Service: 0-800 014 8923 (Toll-free)
Disclaimer: This is not a promotional message, and has been sent to you because of your eminence in the field. If, however, you do not want to receive any email in future from Osteoporosis 2017 then reply us with the subject “remove /unsubscribe”. We concern for your privacy.

Where In the World Is ... Academia Publishing (AP)?

Academia Publishing's About Us web page (8/30/17) begins with a 50-word sentence that boils down to "Academia Publishing  ... includes broad interest titles through the publication of online quality scholarly journals." The page assures readers that
Academia Publishing are using the best available technology ... All articles ... are assign with a DOI number ... Academia Publishing production offers the gold standard in article production, assuring authors of a consistently high quality service across all areas. We are accredited to provide standardized framework for the processes by which high-quality products are created and service given, to the satisfaction of all customers. Academia Publishing aims to demonstrate to societies, editors, authors, and students that there is a robust methodology in place for the management of quality in relation to its operational processes.
Twelve journals are listed on the website (8/30/17) -- a smll number compared to some of the other flaky publishers. The agricultural journal spammed me although my knowledge of agriculture is limited to eating. The email promises that "The editorial board will re-review manuscripts that are accepted pending revision." This will be no mean feat, since the journal lists no editorial board.

The people behind Academia Publishing are not in plain view. The domain academiapublishing.org was registered in 2012 to Contact Privacy Inc. Customer 0135138784, 96 Mowat Ave, Toronto, Canada.The "North America" address on the Contact Us page is the undeliverable "10005, Wall Street, New York, USA." The number is not a location on Wall Street. It is a zip code for hundreds or thousands of addresses.
Email
From: journals.academiapublishing@gmail.com
Sent: Monday, August 28, 2017 5:20 PM
To: journals.academiapublishing@gmail.com
Cc: journals.academiapublishing@gmail.com
Subject: call for paper
We invite you to submit your manuscript(s) for publication. Our objective is to inform authors of the decision on their manuscript(s) within four weeks of submission. Following acceptance, a paper will normally be published in the next issue.
Academia Journal of Agricultural Research (AJAR) is an International High Ranking, open access journal that publishes high-quality articles, in English, in all areas of agricultural science. The journal is covered by CABI, CAB ABSTRACTS in partnership with Thomson Reuters ISI Web of Science.  AJAR is archived in Institutional Library of University of Glasgow, University of Cambridge, University of California, University of Kentucky, University of Edinburgh, University of Groningen - Netherlands, University of Texas,  Ghent University - Belgium, Colorado State University, University of Saskatchewan, University of Oregon, The University of Georgia, University of Southern California, Cornell University, The University of Western Australia and more.
Publication and peer-review process: All manuscripts are reviewed by the Editorial Board and qualified reviewers. Decisions will be made as rapidly as possible, and the journal strives to return reviewers' comments to authors within 2 weeks. The editorial board will re-review manuscripts that are accepted pending revision. All accepted articles will be published online immediately after proof reading and formatting process.
All articles published in AJAR are peer-reviewed. ...
Best regards,
Prof. Jude A, Editor,ajar.academiapublishing@gmail.com
North America: Academia Publishing House, 10005, Wall Street, New York, USA, Tel:  +1 (530) 341-3920, Fax: +1 (877) 289-3847
Europe: Academia Publishing House, King Street, Leeds, West Yorkshire, England, LS1 2HQ 35 094, UK, Tel:  +44 (7087) 626-473, Fax: +44 (8435) 594-498

Friday, August 25, 2017

Avens Journal of Forensic Investigation Checks for Genuinity

The Avens Publishing Group (discussed in a separate posting) is another flaky online publisher pretending (or striving) to be "a vast database of journals." Unlike many of its competitors in India, it solicited me to buy space in a journal on a subject that I do know something about. This Journal of Forensic Investigation is interested in "science and technology elevating the facts, ensuring social justice and well being." The website (8/25/17) explains that
Once a manuscript is submitted, it is assigned to one of our Eminent Editorial Board members to check the genuinity, novelty and quality of research. The manuscript is evaluated by the respective editor within two days of submission. If the manuscript meets the standards of Avens, further proceeding of the manuscript is carried out. The status of acceptance/rejection will be intimated by the editorial office.
Leading the "Eminent Editorial Board" as editor-in-chief is "Dr. Robert W. Allen, Head of the School of Forensic Sciences, Oklahoma State University, USA." Dr. Allen, whose name appears on the boards of other flaky journals, oversees a huge editorial board, A partial list follows. An asterisk by the name indicates that the individual is busy editing other journals of this ilk as well (if their lists of members are to be believed).
Dr. Henry C. Lee, the Director of Forensic Research and Training Center & Distinguished Chair Professor in Forensic Science of University of New Haven, USA.
Dr. Frederic Zenhausern, a Professor and Director of the Center for Applied Nanobioscience and Medicine at the University of Arizona, College of Medicine at Phoenix, USA
Dr. Marcus Rogers, a Professor of Cyber Forensics, University Faculty Scholar and Fellow of the Center for Education and Research in Information Assurance and Security at Purdue University, USA
Dr. John Zheng Wang, a Professor of Criminal Justice and Forensic Science and Director of Applied Forensic Science, Crime Analysis and High Tech Crime Investigation certificate programs, California State University-Long Beach, USA.
Dr. Greg Hampikian, Professor of Biology, and Criminal Justice at Boise State University (BSU), USA.
Dr. Alejandro Del Carmen, a Professor and Chair of the Department of Criminology and Criminal Justice, University of Texas, USA
Dr. Richard C. Li, an Associate Professor of Forensic Biology of John Jay College of Criminal Justice, USA
Dr. Jianye Ge, the Algorithm Leader in the Human Identification Division of Life Technologies
Dr. Alja Videtič Pask, a biochemist with PhD in biochemistry and molecular biology and with 10 years of experience in genetics and epigenetics of psychiatric disorders, ... [no affiliation given]
JFI itself list two special issues: Use of DNA Technology in Forensic Dentistry, edited by "Dr. Lori Baker, Associate Professor of Anthropology, Baylor University, USA," and Forensic Medicine and Pathology, edited by "Dr. Long Jin, Assistant Professor in Clinical Pathology, Louisiana State University Health Science Center, USA." No other information on these issues is present. They have no content. The Articles in Press link returns a blank page. Not a good sign of progress. The Current Issue (5:1) has three articles. A 2013 article labors to reach the conclusion that "understanding of practitioners can be enhanced through continued education at conferences, workshops and other training opportunities." Henry C. Lee & Elaine M. Pagliaro, Forensic Evidence and Crime Scene Investigation, J Forensic Investigation 1(1): 5 (2013).
Email
From: editor.jfi@avenspublishers.com [mailto:editor.jfi@avenspublishers.com]
Sent: Thursday, August 24, 2017 10:01 AM
Subject: Submit your next Article in: Forensic
Dear Dr. David H Kaye,
On behalf of Editors of our JFI, we would like to invite you to make your contribution in the upcoming Summer issue of our journal to spread your research and to disseminate knowledge to the global scientific community by the means of Avens Publishing Group. Journal of Forensic Investigation is an international standard scholarly peer-reviewed journal which means that your paper is available to anyone in the world to download for free directly from our website. It encompasses fostering and enhancing research focuses mainly on forensic medicine, genetics, criminal justice, forensic investigation technology, molecular validation of unknown and controversial relationships, legal proceedings and medical ethics. ...
Submission deadline: 30th September 2017, Issue release date: 25th October 2017
• For Article Processing & Publishing Charges please follow the link below:http://www.avensonline.org/processing-fee/
• All articles are peer-reviewed by our Editorial experts.
• Articles that are found to have been plagiarized or duplicated will be rejected immediately.
If you wish to submit a paper for possible publication in this issue, please contact us and we would be delighted to hear from you.
With regards, Faustina, Managing Editor, Journal of Forensic Investigation, Avens Publishing Group, 47 Hemlock Dr, Northborough MA 01532 USA.

Avens Publishing Group Is "Alive to the Rapidly Growing Research"

Avens Publishing Group looks like another spammer pretending to have a US office. According to Zillow (8/24/17) and other websites, its US address (47 Hemlock Dr, Northborough, MA 01532) is that of a home for sale "in desirable Hemlock Estates" that features a "[m]aple kitchen with center island, granite counters, stainless steel appliances."

The domains avenspublishing.com and avensonline.org are some of a long list registered by
Ashwin Kumar
plotno:505,jyothiraditya apartments,
srinagar colony,
Hyderabad
Andhra Pradesh 5000073 India
Phone: +91.9177734525
The site is hosted in India by Hostgator Asian Operations Division. The domain for the website was purchased through Go Daddy on May 8, 2014. It describes "a vision to encourage the existing scientists, experts and young scientists to enlighten the common society."Although "newly started," Avens' About Us page claims (8/25/17) a "vast database of journals"-- "46 international Open Access peer-reviewed journals with our aim of Inviting Innovations." But this aim, not to mention the enlightment of conmon society, cannot be achieved costlessly. Avens is "seeking for the support from individuals, institutes, libraries, universities, funding agencies, and others" by asking for "a fair price" (that depends on the country of origin).

A webpage on "collaborations" asserts that "over 1400 experts from Industry and Academia provide editorial support to our journals." Moreover, "[w]e, the team at Avens Publishing Group, are alive to the rapidly growing research and believe in developing mutually beneficial relationships to share our good will with other academic institutions, research organization, scientific international ssociations and societies." Alas, this feeling does not seem to be mutual; no such relationships are listed.

The journal that contacted me with regards from "Faustina, Managing Editor" is the Journal of Forensic Investigation. Promising to meet Avens rigorous peer review and publication standards in less than a month, this journal is discussed here.